Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will examine the effects of low-dose naltrexone (LDN) on children with autistic
spectrum disorders. The investigators hope to show a positive effect on social functioning
and language.